NCT03822065View on ClinicalTrials.gov

A Relative Bioavailability Food Effect Study of LY03005

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 16, 2019

Primary Completion Date

February 16, 2019

Study Completion Date

February 16, 2019

Conditions
Major Depressive Disorder
Interventions
DRUG

LY03005

80 mg oral tablet single dose

Trial Locations (1)

21201

Pharmaron CPC, Inc., Baltimore

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT03822065 - A Relative Bioavailability Food Effect Study of LY03005 | Biotech Hunter | Biotech Hunter